These symptoms arise primarily because GLP-1 medications slow gastric emptying, a key mechanism that helps control blood glucose and appetite
GLP-1s mimic these actions and, as theyre resistant to the enzyme DPP4, have a longer-lasting impact on our appetite
As opposed to PCD, SCD occurs due to, or in association with, other disorders such as liver or kidney disease, defects in fatty acid metabolism, or administration of pharmacological agents such as pivampicillin or valproic acid (discussed below) [27, 41, 42]
34: 131420 Rodrguez-Segade S, de la Pea CA, Paz M, et al
In recent years, Tirzepatide has emerged as a transformative treatment option in diabetes management, offering substantial benefits not only in glycemic control but also in weight management
The effects of vitamin E and vitamin C supplementation on bioenergetics index